Ausgabe 9/2011
Inhalt (14 Artikel)
Therapeutic effects of metformin in breast cancer: involvement of the immune system?
- Opinion Paper
Sarah Schott, Angelika Bierhaus, Florian Schuetz, Philipp Beckhove, Andreas Schneeweiss, Christof Sohn, Christoph Domschke
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses
- Original article
Sofia R. Gameiro, Jorge A. Caballero, Jack P. Higgins, David Apelian, James W. Hodge
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine
- original article
Mengyong Yan, Nourredine Himoudi, B. Piku Basu, Rebecca Wallace, Edmund Poon, Stuart Adams, Fyeza Hasan, Shao-An Xue, Natalie Wilson, Angus Dalgleish, Owen Williams, John Anderson
Immunotherapy eradicates metastases with reversible defects in MHC class I expression
- Original article
Cristina Garrido, Irene Romero, Enrique Berruguilla, Bárbara Cancela, Ignacio Algarra, Antonia Collado, Angel García-Lora, Federico Garrido
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancy
- Original article
Bethany L. Mundy-Bosse, Gregory S. Young, Todd Bauer, Elaine Binkley, Mark Bloomston, Matthew A. Bill, Tanios Bekaii-Saab, William E. Carson III, Gregory B. Lesinski
Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4+ and CD8+ T cells
- Original article
Kristan D. Guenterberg, Gregory B. Lesinski, Bethany L. Mundy-Bosse, Volodymyr I. Karpa, Alena Cristina Jaime-Ramirez, Lai Wei, William E. Carson III
Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response
- Original article
Akitaka Takahara, Shigeo Koido, Masaki Ito, Eijiro Nagasaki, Yukiko Sagawa, Takeo Iwamoto, Hideo Komita, Toshiki Ochi, Hiroshi Fujiwara, Masaki Yasukawa, Junichi Mineno, Hiroshi Shiku, Sumiyuki Nishida, Haruo Sugiyama, Hisao Tajiri, Sadamu Homma
MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing
- Original article
Lei Bao, Kimberly Dunham, Kenneth Lucas
Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN
- Original article
S. M. Geary, C. D. Lemke, D. M. Lubaroff, A. K. Salem
CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells
- Original article
Cheryl E. Myers, Paul Hanavan, Kwasi Antwi, Daruka Mahadevan, A. Jamal Nadeem, Laurence Cooke, Adrienne C. Scheck, Zachary Laughrey, Douglas F. Lake
A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4+ and CD8+ T-cell as well as B-cell responses
- Original article
Frank Neumann, Boris Kubuschok, Kubilay Ertan, Claudia Schormann, Stefan Stevanovic, Klaus-Dieter Preuss, Werner Schmidt, Michael Pfreundschuh
Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model
- Original Article
David M. Foureau, Iain H. McKillop, Chase P. Jones, Asim Amin, Richard L. White, Jonathan C. Salo
Obituary: Joseph Lustgarten, 1963–2011
- Short communication
Suzanne Ostrand-Rosenberg, Esteban Celis, Peter Cohen, Zelig Eshher, Sandra Gendler, Dominique Hoelzinger, Arthur Hurwitz, Larry Pease, Linda Sherman
